| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $111.2M | -3.3% |
| Cost of Revenue | $76.9M | -2.9% |
| Gross Profit | $34.3M | -4.4% |
| R&D Expense | $343K | — |
| SG&A Expense | $16.6M | +25.6% |
| Operating Income | $6.8M | -47.3% |
| Pre-tax Income | $4.2M | -66.7% |
| Income Tax | $1.0M | -51.9% |
| Net Income | $3.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $6.6M | -31.1% |
| Inventory | $27.3M | +5.6% |
| Current Assets | $45.4M | +18.3% |
| Total Assets | $56.7M | +35.2% |
| Current Liabilities | $26.1M | +38.9% |
| Total Liabilities | $33.6M | +22.4% |
| Stockholders' Equity | $23.1M | +59.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $6.7M | -38.9% |
| Capital Expenditures | $388K | +188.0% |
| Investing Cash Flow | -$226K | -86.4% |
| Financing Cash Flow | $3.0M | +127.3% |
| Free Cash Flow | $6.3M | -41.7% |
| -69.7% |
| EPS (Basic) | $0.08 | -69.2% |
| EPS (Diluted) | $0.08 | -69.2% |